The honorees are scheduled to deliver lectures during this year’s meeting in San Diego, CA, which runs from April 17-22.

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today advised that its audited consolidated financial statements for the fiscal year ended December 31, 2025, contained an audit ...

O'Cearbhaill, MD, of Memorial Sloan Kettering Cancer Center discussed the rationale and early progress of a phase 1/2 ...

Trial Combines LIXTE’s LB-100 with Dostarlimab; Results Give Patients New Hope for a Challenging Disease with Limited Therapeutic Options-BOCA ...

Therapeutic cancer vaccines have the potential to induce durable and tumor-specific immune responses in addition to the widely used immune checkpoint blockade therapies. These vaccines aim to ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

A bacterium from frog gut microbiota eliminated tumors in mice by selectively colonizing tumors and triggering both direct ...

Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...

A common eye-health nutrient, zeaxanthin, may also help the body fight cancer more effectively. Scientists discovered it strengthens T cells and enhances the impact of immunotherapy treatments. Found ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...